Why is Oxygenta Pharma falling/rising?

As of 17-Oct, Oxygenta Pharmaceutical Ltd is experiencing a price increase, currently at Rs 65.95, reflecting a rise of 3.14 (5.0%). The stock has shown strong performance today, outperforming its sector by 4.53% and has been on a consecutive gain streak for the last four days, accumulating a total return of 16.99% during this period. Although the stock has a year-to-date decline of 24.60% and a one-year drop of 30.29%, it has demonstrated impressive long-term growth with a 3-year return of 143.81% and a 5-year return of 803.42%. However, it is important to note that there is a significant drop in investor participation, with delivery volume falling by 77.39% against the 5-day average.
In the broader market context, Oxygenta's short-term performance over the past week has been notably strong, with a return of 12.37%, significantly outperforming the Sensex, which only gained 1.76% during the same period. This indicates that while the stock is currently rising, it has faced challenges over the longer term compared to the benchmark, as evidenced by its negative returns over the past month and year. The stock's liquidity remains adequate for trading, but the declining delivery volume suggests a potential concern regarding sustained investor interest moving forward.